Today’s top gainers include the company Allergan plc (NYSE:AGN) which is in the industry Drugs – Generic, gaining -0.48% today. In the last week its performance is 4.07%, and -3.17% for the past quarter. Currently, Allergan plc, AGN has a target price of 293.06, so today’s gain of -0.48% is a significant step towards its target price. The GAP today is therefore -0.31%.
Allergan plc (NYSE:AGN), has a market cap of 92564.39, and is based in USA. Insider ownership is at 0.10%, and institutional ownership is 89.80%.
At the current price of 235.85, it has a dividend yield of 0.08%, and its target price is 293.06. This is with a profit margin of *TBA, and total debt/equity of 0.59. Allergan plc (NYSE:AGN) has a P/E of *TBA, as well as a forward P/E of 13.66.
With a current EPS of -5.63, and a forecasted EPS growth for next year at 22.02%,Allergan plc (NYSE:AGN) has had a EPS growth for the past five years at -50.40%. For the next five years EPS growth is projected to be 9.70%.
Performance for the year is -22.81%. Since its IPO date on 2/17/1993, the total performance to date is -24.17%.
Volume today for Allergan plc (NYSE:AGN), is 594991, while its average volume is 4372.76. Whilst the total gain today was -0.48%, it did have a day high of -6.12%.
Volatility for this week has been at 2.40%, and 2.55% for the month. The 52-week low for Allergan plc, AGN has been 20.64%, while the 52-week-high has reached -30.70%.
Looking at its return of investments, which is -1.30%, and its return on assets is *TBA. Allergan plc (NYSE:AGN) has an operating margin of *TBA. With a sales growth of 48.10% quarter over quarter. Bearing in mind that Allergan plc, AGN is in the sector Healthcare, its long-term debt/equity is 0.53, and has a current ratio of 1 and 0.9 for quick ratio.
So what is the value of Allergan plc? Well its PEG is *TBA, and the P/S is 5.68, along with a P/B of 1.29. Meanwhile it has a p/cash of 40.71.